Description

4(3H)-Quinazolinone, 3-Ethyl-8-Hydroxy-2-Methyl-7-(Piperidinomethyl)- (7Ci) is a specialized quinazolinone derivative, a heterocyclic scaffold of significant interest in advanced organic synthesis. This compound matters as a key synthetic intermediate or potential pharmacophore for developing novel bioactive molecules, particularly in pharmaceutical research. It is needed by R&D chemists and process development scientists in the pharmaceutical, agrochemical, and fine chemical industries for creating new active ingredients and exploring structure-activity relationships.

Application

• Pharmaceutical Intermediate: Serves as a crucial building block for the synthesis of novel drug candidates, particularly those targeting central nervous system (CNS) disorders, inflammation, or oncology.
• Medicinal Chemistry Research: Used extensively in hit-to-lead optimization and lead compound development programs due to its modifiable quinazolinone core.
• Biochemical Tool Compound: Employed in vitro and in vivo studies to investigate specific biological pathways and enzyme interactions.
• Agrochemical Development: Acts as a precursor in the research and synthesis of new pesticides or herbicides with novel modes of action.
• Academic & Institutional Research: Utilized in universities and research institutes for fundamental studies in heterocyclic chemistry and organic synthesis methodologies.
• Fine Chemical Synthesis: Incorporated into complex molecular architectures requiring the specific functionalization pattern of this quinazolinone derivative.

Basic Information

Product Name	4(3H)-Quinazolinone, 3-Ethyl-8-Hydroxy-2-Methyl-7-(Piperidinomethyl)- (7Ci)
CAS No.	94803-83-5
Molecular Formula	C₁₇H₂₃N₃O₂
Molecular Weight	301.39 g/mol
Synonyms	3-Ethyl-8-hydroxy-2-methyl-7-(piperidin-1-ylmethyl)quinazolin-4(3H)-one; 7-(Piperidinomethyl)-3-ethyl-8-hydroxy-2-methyl-4(3H)-quinazolinone; 3-Ethyl-8-hydroxy-2-methyl-7-piperidin-1-ylmethyl-3H-quinazolin-4-one; 94803-83-5; 3-Ethyl-8-hydroxy-2-methyl-7-(piperidinomethyl)-4(3H)-quinazolinone; 7-(Piperidin-1-ylmethyl)-3-ethyl-8-hydroxy-2-methylquinazolin-4(3H)-one
EINECS	Contact for details

Quality Control

Our 4(3H)-Quinazolinone derivative is produced under strict quality management protocols. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via spectroscopic methods (NMR, IR, MS), to ensure it meets the high standards required for research and development. Certificates of Analysis (COA) with detailed chromatographic data are provided with every shipment. We adhere to cGMP principles where applicable to ensure consistent quality and traceability.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). Keep away from incompatible materials. The container should be kept tightly sealed to protect the contents from moisture and atmospheric contamination.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference standard
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.